As an antitumor and antiangiogenic factor, human cytosolic SerRS appears to be a promising drug target and therapeutic agent for treating cancer, cardiovascular diseases, and possibly obesity and aging. This evidence concerns the gene SARS1 and obesity due to melanocortin 4 receptor deficiency.